Perfil
Tobias Larsson Agervald is Chief Executive Officer at Guard Therapeutics International AB since 2019 and Director at TE Medical Consulting AB since 2018.
Former roles include Senior Medical Director at Astellas Pharma Global Development, Inc. and Associate Professor at Karolinska Institutet.
Education includes doctorates from the University of Uppsala and Harvard Medical School.
Cargos activos de Tobias Larsson Agervald
| Empresas | Cargo | Inicio |
|---|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Director Ejecutivo | 15/01/2019 |
TE Medical Consulting AB | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Tobias Larsson Agervald.
| Empresas | Cargo | Fin |
|---|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director Técnico/Científico/I+D | - |
Formación de Tobias Larsson Agervald.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Guard Therapeutics International AB
Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
TE Medical Consulting AB |
- Bolsa de valores
- Insiders
- Tobias Larsson Agervald
















